Detalhe da pesquisa
1.
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
N Engl J Med
; 384(3): 238-251, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332778
2.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
N Engl J Med
; 385(13): 1184-1195, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347950
3.
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
N Engl J Med
; 385(23): e81, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587383
4.
MESMERIC: Machine Learning-Based Trust Management Mechanism for the Internet of Vehicles.
Sensors (Basel)
; 24(3)2024 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339580
5.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough.
Lung
; 201(1): 25-35, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512069
6.
Towards a Machine Learning Driven Trust Management Heuristic for the Internet of Vehicles.
Sensors (Basel)
; 23(4)2023 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36850923
7.
Dynamic Correlation Adjacency-Matrix-Based Graph Neural Networks for Traffic Flow Prediction.
Sensors (Basel)
; 23(6)2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36991611
8.
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19.
J Infect Dis
; 227(1): 23-34, 2022 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895508
9.
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial.
Clin Infect Dis
; 75(1): e380-e388, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219277
10.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
JAMA
; 327(5): 432-441, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029629
11.
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial.
Open Forum Infect Dis
; 10(5): ofad211, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37229174
12.
Perturb and optimize users' location privacy using geo-indistinguishability and location semantics.
Sci Rep
; 12(1): 20445, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36443506
13.
Privacy preserving dynamic data release against synonymous linkage based on microaggregation.
Sci Rep
; 12(1): 2352, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149712
14.
Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies.
mBio
; 13(6): e0169922, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36255239
15.
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
JAMA Netw Open
; 5(8): e2225411, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969402
16.
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Int J Infect Dis
; 122: 585-592, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788416
17.
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Lancet Infect Dis
; 22(10): 1444-1454, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803290
18.
Dataset for toothbrushing activity using brush-attached and wearable sensors.
Data Brief
; 37: 107248, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34277901
19.
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
medRxiv
; 2021 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159343
20.
Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention.
medRxiv
; 2021 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159344